ARCHIVE

• Meet the Leaders (15)
  February 17, 2003

• Dr Calfee Points Out Lack of Freedom Hits Drug Industry in Germany, Japan: PhRMA Seminar
  February 17, 2003

• MEDICAL FACILITIES & NURSING CARE NEWS IN BRIEF
  February 17, 2003

• Dainippon Wishes to Sharply Recover from Next Fiscal Year
  February 17, 2003

• Report Highlights Growing Profitability of Matsumotokiyoshi
  February 17, 2003

• Teijin Aims at \105 Bil. Pharma Sales in FY2005
  February 17, 2003

• Voluntary Standards Established for Gingko Biloba, B. Natto Extracts
  February 17, 2003

• Mr Nagayama Offers Proposals to Stimulate FDI in Japan
  February 17, 2003

• OTC NEWS IN BRIEF
  February 17, 2003

• WORLD NEWS IN BRIEF
  February 10, 2003

• Takeda: 4 Global Strategic Products Saw Continued Growth in 3rd Qtr
  February 10, 2003

• BULLTIN
  February 10, 2003

• CORPORATE ROUNDUP NEWS IN BRIEF
  February 10, 2003

• 100% Acquisition to Eliminate Wall Between Merck, Banyu
  February 10, 2003

• Chuikyo to Discuss Additional NHI Price Cuts for Long-listed Original Drugs
  February 10, 2003

• GSK, Sankyo Agree to Copromote Type 2 Diabetes Drug, Rosiglitazone
  February 10, 2003

• Korosho to Start Disease-related Protein Analysis Project
  February 10, 2003

• Teijin, Kyorin to Strengthen Business in Respiratory Field
  February 10, 2003

• Bio-derived Products Total 189 Ingredients
  February 10, 2003

• Aventis to Transfer Suvenyl Manufacturing Rights to Chugai
  February 10, 2003

ページ

• « 先頭
• ‹ Prev
• …
• 619
• 620
• 621
• 622
• 623
• 624
• 625
• 626
• 627
• …
• Next ›
• 最終 »